Lv11
50 积分 2026-01-15 加入
A pharmacogenetic pilot study of CYP2C9 common genetic variant and sulfonylureas therapeutic response in type 2 diabetes mellitus patients
2个月前
已完结
Association of SLC22A1 rs622342 and ATM rs11212617 polymorphisms with metformin efficacy in patients with type 2 diabetes
2个月前
已完结
Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes
2个月前
已完结
A twin study of the trough plasma steady-state concentration of metformin
2个月前
已完结
Pharmacogenetics and pharmacogenomics of anticancer agents
2个月前
已完结
Adverse drug reactions to anti-diabetic drugs are commonest in patients whose treatment do not adhere to diabetes management clinical guidelines: cross-sectional study in a tertiary care service in sub-Saharan Africa
2个月前
已完结
Causes and consequences of discontinuation of GLP1RAs or tirzepatide
2个月前
已完结
Initial monotherapy with either metformin or sulphonylureas often fails to achieve or maintain current glycaemic goals in patients with Type 2 diabetes in UK primary care
2个月前
已完结
Medicinal Chemistry, SAR, and Molecular Insights Into 2,4-Thiazolidinediones as Antidiabetic Agents (2020-2025)
2个月前
已完结
Is the steady-state concentration, duration of action, or molecular weight of GLP-1RA associated with cardiovascular and renal outcomes in type 2 diabetes?
2个月前
已完结
皖公网安备34019202002308
